Filling the need for trusted information on national health issues

Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Progress Toward TB Elimination Requires Collective Effort To Develop Novel, Effective Vaccines

PLOS Medicine: Tuberculosis vaccines: Rising opportunities Johan Vekemans, medical officer at the Initiative for Vaccine Research at the WHO; Katherine L. O’Brien, director of the WHO’s Department of Immunization, Vaccines and Biologicals; and Jeremy Farrar, director of Wellcome “…[T]ransforming discovery and vaccine candidates into products that can have impact takes…

Professor Discusses Efforts To Address Meningitis In Burkina Faso

CDC’s “Our Global Voices”: From Mangoes to Meningitis: A Tale of One Laboratory Scientist in Burkina Faso Rasmata OuĂ©draogo-TraorĂ©, chief of the Medical Analysis Laboratory of the Charles De Gaulle Pediatric Hospital, which houses the National Reference Laboratory for meningitis in Burkina Faso, and professor of bacteriology-virology, medical sciences, and…

More News In Global Health

Al Jazeera: U.N. raises Libya aid alarm as Tripoli clashes intensify (4/22). The BMJ: Breast ironing (Robinson, 4/23). Business Live: Research buzzes along but science is still scratching the surface of beating malaria (Oliver, 4/23). Devex: Q&A: How Gavi can adapt to tackle equity and conflict (Igoe, 4/23). Devex: Q&A:…

More News In Global Health

Agence France-Presse: Yemen risks ‘massive resurgence’ of cholera: Oxfam (4/19). Bloomberg: Cholera Hits Kenyan Capital on Shortage of Clean Water: Report (Doya, 4/20). The Guardian: ‘The harder you look the more you find’: Nepal’s hidden leprosy (Ratcliffe, 4/22). Health Policy Watch: DNDi: ‘Bench-To-Bedside’ Approach Needed For Drug & Vaccine Response…

CFR Expert Discusses Success Of Experimental Ebola Vaccine In DRC

Council on Foreign Relations’ “Africa in Transition”: The Ebola Vaccine Is Highly Effective in Eastern Congo John Campbell, Ralph Bunche senior fellow for Africa Policy Studies at CFR, discusses the success of an experimental Ebola vaccine developed by Merck & Co being used in the Democratic Republic of the Congo…

GSK, Partners To Begin Pilot Program For Malaria Vaccine In Africa This Month; Sanaria Experimental Malaria Vaccine To Begin Large Trial On African Island In 2020

Bloomberg: Malaria Vaccine Took 30 Years. It’s Still a Work in Progress “After more than three decades of work and almost $1 billion of investment, GlaxoSmithKline Plc and its partners are ready to deploy a vaccine for malaria, the mosquito-borne disease that kills almost half a million people each year.…